ulcerative coliits
Conditions
Interventions
experimental group:Qingshen decoction+ mesalazine
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients who met the diagnostic criteria of UC colonoscopy within the last 1 month met the UC manifestations mucosal biopsy met the UC active stage manifestations the lesion range classification met the Montreal classification E1 E2 E3 and the disease severity classification was moderate UC (Mayo score 6-10); (2) In line with the TCM standards of large intestine damp-heat syndrome differentiation; (3) Age between 18 and 75 years old regardless of gender; (4) Voluntary and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Those who were or were being treated with anti-TNF hormones methotrexate antibiotics or other biologics within 3 months prior to inclusion; (2) severe liver and kidney dysfunction other autoimmune diseases or malignant tumors; (3) Patients with bacterial dysentery intestinal tuberculosis and other infectious intestinal diseases as well as ischemic enteritis colorectal cancer and other intestinal diseases Tao disease; (4) Patients with a history of severe mental illness; (5) Patients with Chinese or western drug allergy and intolerance in this study; (6) Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical remission rate of UC; | — |
Secondary
| Measure | Time frame |
|---|---|
| Mucosal healing rate after treatment;Total effective rate of TCM syndromes;The recovery rate of symptoms after treatment;Changes in symptoms before and after treatment;UC clinical response rate; | — |
Countries
China
Contacts
Public ContactJiang Lin
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed